Laura Angelini is a seasoned trial lawyer with a national practice defending health care organizations and executives in high-stakes government investigations. She represents clients in civil, criminal and administrative actions involving the False Claims Act, Anti-Kickback Statute, Stark Law, HIPAA and other core fraud and abuse laws. Her matters frequently involve alleged Medicare and Medicaid billing violations, off-label promotion, drug diversion and patient privacy breaches.
Laura’s clients include pharmaceutical and medical device manufacturers and distributors, hospitals and academic medical centers, behavioral health organizations, physician practice groups and licensed professionals. She also counsels educational institutions, faculty and students in Title IX and campus misconduct proceedings, particularly where civil or criminal liability is at stake. Outside of health care, Laura has handled enforcement matters in the construction, public procurement, securities and financial services sectors.
Education
- Boston College Law School (J.D., 2003)
- Boston College Environmental Affairs Law Review, Executive Editor
- Boston College (B.A., magna cum laude, 2000)
- English
Bar Admission
- Massachusetts
Professional Affiliations
- Instructor, National Institute of Trial Advocacy (NITA), 2016-Present
- Women’s White Collar Defense Association (Boston Chapter)
- American Health Lawyers Association
- American Heart Association, Board Member
Recognition
- Selected for inclusion in Best Lawyers in America® for:
- Business Organizations (including LLCs and Partnerships), 2021-2025
- Commercial Litigation, 2021-2025
- Criminal Defense: White-Collar, 2021-2025
- Litigation – Health Care, 2025
- Recognized as a Top Lawyer in Criminal Defense White Collar by Boston Magazine, 2021-2023
- Recognized in Massachusetts Super Lawyers® in Criminal Defense/White Collar, 2014-2023
- Named to the Top 50: Women Massachusetts 2024 and Top 100: Massachusetts 2024
- Honored among the Top Women of Law by Massachusetts Lawyer’s Weekly, 2022
